Debating the morning after

The week's news at a glance.

Washington, D.C.

Federal regulators this week rejected a request to sell a morning-after birth-control pill without a prescription. The drug, Plan B, can prevent ovulation or keep a fertilized egg from implanting if taken within 72 hours of sex. The Food and Drug Administration said drug maker Barr Pharmaceuticals had failed to prove girls could safely use Plan B without a doctor’s help. Conservative activist Wendy Wright praised the ruling, saying the drug was too potent to be sold “next to candy bars and toothpaste.” But birth-control advocate Kirsten Moore said the decision denied women “a safe, proven second chance to prevent pregnancy.”

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Sign up

Explore your latest briefing

Explore your latest briefing